Search Results

patient advocacy, community oncology, and health information technology representatives, to review the existing quality landscape and identify contemporary, relevant cancer quality and outcomes measures by both reevaluating current validated measures and

trial and update of systematic review . Lancet 2007 ; 369 : 1929 – 1937 . 27. Dautzenberg B Benichou J Allard P . Failure of the perioperative PCV neoadjuvant polychemotherapy in resectable bronchogenic non-small cell carcinoma. Results

. Immunotherapy of metastatic renal cell cancer . Review . Cancer Control 2002 ; 9 : 293 – 304 . 3 Motzer RJ Bander NH Nanus DM . Renal-cell carcinoma . N Engl J Med 1996 ; 335 : 865 – 875 . 4 Motzer RJ Mazumdar M Bacik J . Survival

reviewed by an independent national process called the pan-Canadian Oncology Drug Review (pCODR), a branch of Canadian Agency for Drugs and Technologies in Health (CADTH). With the stated objective “to bring consistency and clarity to the assessment of

Drug Development Programs: Designation, Development, and Application Review. Washington, DC , United States Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics

and effectively treated with an ICI. We also review the literature on immunotherapy use in patients with other metastatic solid tumors after liver transplant and those with baseline liver function abnormalities. Case Presentation A 61-year-old man with

. Grading of soft tissue sarcomas. Review and update . Arch Pathol Lab Med 2006 ; 130 : 1448 – 1453 . 26. Hasegawa T Yamamoto S Yokoyama R . Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft

participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation at www.medscapecme.com/journal/jnccn ; (4) view

of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at www

Background: Peer review is an important quality assurance (QA) tool in cancer care. For radiotherapy (XRT), peer review is challenging because of the complexity of XRT targets and treatment planning and significant patient numbers. During review